Clinical Trial Update: Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effects of Fumaria parviflora L. on pruritus in patients with end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Pruritus

Drugs mentioned

• Fumaria parviflora L.

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: End-Stage Renal Disease, Pruritus | Phase 2 | Status: COMPLETED